Sylvain Celanire is CEO and member of the Board of Director. He is an experienced entrepreneur and R&D director in the life science sector, with extensive expertise in the discovery and development of new medicines in the neuroscience therapeutic area within several European pharmaceutical and biotech companies, such as UCB New Medicines in Belgium where he started his career in 2002. ​

In 2015, he co-founded PRAGMA Therapeutics, a French biotech company specializing in the development of innovative medicines for sensory-neural hearing loss and neuropsychiatric disorders, winner of the UK OBN Bioseed™ “One-to-Watch” award in 2018. Sylvain holds a PhD in medicinal chemistry from the University of Rouen with postdoctoral fellowships at the Universities of Orleans (France) and of Oxford (UK).​

Sylvain Celanire​

2021 all rights reserved.

mail us